Informations techniques
Exploitant
Laboratoires PROSTRAKAN PHARMA
Présentation
DROLEPTAN 2,5 mg/ 1ml, solution injectable (IV) B/10 - CIP 561 122-8
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
GuQbD3vpsBYpzz91